Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Transocean Ltd (RIG) Price & Performance

Alnylam Pharmaceuticals, Inc.Trade
Transocean LtdTrade

Price performance (Past 24H)

Key statistics

Alnylam Pharmaceuticals, Inc. vs Transocean Ltd — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $222.98 (market cap $29.60B), while Transocean Ltd trades at $5.81 (market cap $6.49B). The key difference: Alnylam Pharmaceuticals, Inc. is far larger — about 4.6× Transocean Ltd's market cap, and Transocean Ltd is trading nearer its 52-week high, Alnylam Pharmaceuticals, Inc. nearer its low. Which is the better fit depends on your goals.

ALNYRIG
Market Cap
$29.60B$6.49B
Sector
HealthTechnology
52-Week High
$491.22$7.58
52-Week Low
$205.48$2.80
Enterprise Value
$27.56B$11.10B

Returns comparison

Trailing returns across standard periods

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.

Read more on ALNY

About Transocean Ltd

Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.

Read more on RIG